NEWS
Health Sciences Newsroom
December 01, 2022 | Features Stephanie Cherqui, PhD and Alysson R. Muotri, PhDScientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ DiseaseCIRM grant will fund novel gene therapy aiming for one-time, lifelong treatment of Friedreich’s ataxia, a progressive neuromuscular disorder; second CIRM grant will advance efforts to leverage UC San Diego research on another rare disease |
November 03, 2022 | Features Alysson R. Muotri, PhDOrganoids Reveal How SARS-CoV-2 Damages Brain Cells — and a Potential TreatmentUsing human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses — the connections between brain cells that allow them to communicate with each other. |
October 18, 2022 | Features Victor Nizet, MDUC San Diego Physician-Scientist Elected to National Academy of MedicineVictor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine. In officially announcing Nizet’s election, NAM credited Nizet "for discovering numerous hallmark virulence mechanisms of bacterial pathogens and key roles of antimicrobial peptides, neutrophils and macrophages in innate immunity. His translational research has yielded innovative approaches to counteract the threats of antibiotic resistance and sepsis." |
2022 | Features Mamata Sivagnanam, MD Mamata Sivagnanam, MD, Selected to be New Pediatric Residency Program DirectorIt is with great pleasure we announce that Mamata Sivagnanam, MD will be the new Pediatric Residency Program Directory, the role currently held by Dr. Mark Sawyer. Dr. Sivagnanam was selected for this position after a vigorous national recruitment and a unanimous recommendation by the search committee that was fully supported by select faculty members and department leaders. |
August 11, 2022 | Features Brookie Best, PharmD Meet Dr. Brookie Best, Dean of the Skaggs School of Pharmacy and Pharmaceutical SciencesBrookie Best was named new dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences, succeeding James McKerrow, who stepped down in June after serving as dean for seven years. Best is a familiar face. She joined Skaggs faculty in 2003, just one year after the school opened its doors to its first class, rising to professor of clinical pharmacy and pediatrics and associate dean for pharmacy education. Her contributions span the school’s missions of research, education and clinical care.
|
June 27, 2022 | Features Jeffrey Schwimmer, MD New Genetic Associations in Pediatric NAFLD Affect Both Risk and SeverityPaired studies in children further identify differences between pediatric and adult diseases and may inform future treatments in a chronic childhood disease. In a pair of overlapping studies, a diverse team of researchers, led by scientists at University of California San Diego School of Medicine, have deepened investigations into the genetic origins of nonalcoholic fatty liver disease (NAFLD) in children, describing multiple gene variants (including some previously unknown) that contribute to the risk of developing NAFLD and gene variants associated with the severity of the liver disease. The findings published in the June 25, 2022 online issue of the journal Hepatology . |
November 4, 2021 | Features Smruthi Karthikeyan, postdoc researcher, and Rob Knight, PhD The Proof is in the PoopSmruthi Karthikeyan, an environmental engineer and postdoctoral researcher, works in the lab of Rob Knight at UC San Diego School of Medicine. Researchers in Knight’s lab are used to getting their hands dirty. The team has long been known for their studies of the gut microbiome—the unique communities of microbes that live in our gastrointestinal tracts. By the summer of 2020, Karthikeyan, Knight and team were sifting through fecal samples closer to home —sewage flushed away by people occupying UC San Diego buildings—to look for the virus that causes COVID-19. |
October 27, 2021 | Features Alysson Muotri, PhD, and Sheldon Morris, MD San Diego Research Centers Receive $15 million to Train Next Generation of ScientistsThree San Diego research institutions have been awarded nearly $15 million from the California Institute of Regenerative Medicine (CIRM) to train the next generation of scientists in regenerative medicine, a field of research that holds great promise for generating transformative medicines. Scripps Research, University of California San Diego, and Sanford Burnham Prebys each received grants of around $5 million from CIRM to support the training of graduate students, postdoctoral trainees, and clinical trainees. |
October 27, 2021 | Features Rob Knight, PhD Is it OK to go Trick-or-Treating in San Diego this Halloween?UC San Diego biologist and microbiome researcher Rob Knight, who worked with microbial ecologist Forest Rohwer to do the candy study last year, said in an email Wednesday that Delta does give him reason to continue advising caution this year. |
October 26, 2021 | Features Elizabeth Winzeler, PhD, JoAnn Trejo, PhD, MBA, and David A. Brenner, MD, vice chancellor, health sciences Rancho Santa Fe scientist elected to National Academy of MedicineRancho Santa Fe’s Elizabeth Winzeler, a leader in anti-malarial drug development, was recognized by her peers with one of the highest honors in health and medicine—she was recently elected to the National Academy of Medicine. Winzeler, PhD, is a professor in the division of host microbe systems and therapeutics in the department of pediatrics at UC San Diego School of Medicine and an adjunct professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego. |
October 26, 2021 | Features Jane Burns, MD, and Ben Croker, PhDSame Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 ReactionResearchers look at the use of intravenous immunoglobulin for treatment of Kawasaki disease and multisystem inflammatory syndrome in children, a rare reaction to SARS-CoV-2. |
October 25, 2021 | Features Mark Sawyer, MDFDA advisory committee to review data on Pfizer's COVID-19 vaccine for kids ages 5 to 11The Food and Drug Administration’s (FDA) vaccine advisory committee will meet to review data on the safety and efficacy of Pfizer’s COVID-19 vaccine in children ages 5 to 11. |
October 21, 2021 | Features Alessandra Franco, MD, PhDChildren with MIS-C Mount Normal T-cell Response to SARS-CoV-2, Study FindsChildren with an inflammatory syndrome linked to SARS-CoV-2 infection mount a normal T-cell response to the virus, according results from a multi-institutional study reported in the European Journal of Immunology. Researchers had hypothesized that multisystem inflammatory syndrome in children (MIS-C) may result from an abnormal T-cell response against the virus, leading to inflammation. |
September 16, 2021 | Edmund Capparelli Edmund Capparelli Receives Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and TherapeuticsEdmund Capparelli, PharmD is the 2021 recipient of the Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics. This award is given annually in recognition of significant and sustained contributions toward the improvement of children's health through the expansion of the field of pediatric pharmacology and therapeutics. |
September 10, 2021 | AnnouncementUC San Diego School of Medicine Awarded $6.1M to Study Effects of Maternal Antibiotic Use on Infant Health in New Collaborative Research CenterResearchers at University of California San Diego School of Medicine have received a $6.1 million grant to launch a new Center of Excellence in Therapeutics (CET). The CET will study the effects of medications on human milk and infant health. The research team includes division members Adriana Tremoulet (lead PI), Victor Nizet, George Liu, Pieter Dorrestein, and Brookie Best. |
September 9, 2021 | Features Maike Sander, MD, PhD, and Kyle Gaulton, MD$6M NIH Grant Launches UC San Diego Consortium to Study Insulin-Producing CellsUniversity of California San Diego School of Medicine researchers will receive $6.4 million in grant funding to study how external signals and genetic variations influence the behavior of one cell type in particular: insulin-producing beta cells in the pancreas. |
September 8, 2021 | Features Christina Chambers, PhD, MPH, and Kerri Bertrand, research mananger Study: No Serious COVID-19 Vaccine Side Effects in Breastfeeding Moms, InfantsResearchers found after Pfizer and Moderna vaccine, breastfeeding mothers experienced similar side effects to what has previously been reported in non-breastfeeding women, and infants exhibited no serious side effects. |
September 3, 2021 | Features Debashis Sahoo, PhD Researchers Replicate COVID-19 Infections with Lab-Grown 'mini-lungs'Researchers at the University of California, San Diego (UCSD) have grown miniature human lungs in a lab dish that they say come the closest to mimicking the real thing—complete with all the myriad cell types found in the body. |
July 29, 2021 | Chris Cannavino, MDSpecial Announcement: Chris CannavinoWe are very pleased to announce that Christopher Cannavino, MD has been selected for the 2020-2021 Barbara and Paul Saltman Distinguished Teaching Award for Non-Senate Members. |
June 2, 2021 | Features Alysson Muotri, PhDAlysson Muotri: A Brain Begins – in a DishBy coaxing skin cells to become brain cells in a dish, Alysson Muotri hopes to learn how early brain development can go wrong in conditions like autism or epilepsy – and how our brains differ from those of our cousins, the Neanderthals. |
March 30, 2021 | Karen Mestan, MD
Announcement: Karen Mestan, MD, New Division Chief for NeonatologyIt is with great pleasure that we announce Karen K. Mestan, MD will be joining the Department of Pediatrics at UC San Diego and Rady Children’s Hospital this fall as Division Chief of Neonatology. Dr. Mestan is currently an attending neonatologist at Lurie Children's Hospital and Northwestern University Feinberg School of Medicine. She is an active clinician, researcher and teacher. Her research focuses on identifying biochemical, environmental, and genetic markers for preterm birth and its complications. She is also interested in understanding perinatal factors that determine long term health. |
March 29, 2021 | Tariq Rana, PhD
Professor Tariq Rana Inducted into National Academy of Inventors!We are pleased to announce that Dr. Tariq Rana, a multidisciplinary RNA Biologist, has been named a 2020 fellow of the National Academy of Inventors (NAI). The NAI Fellows are chosen for a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development, and the welfare of society. Election to NAI fellow status is the highest professional distinction accorded solely to truly prolific academic inventors. |
February 24, 2021 | Features Toluwalase Ajayi, MD
Midday Edition Special: Racism Fuels A Public Health Crisis In Black Maternal And Infant HealthIn San Diego County, Black women are three times more likely to die due to pregnancy or delivery complications than white woman and Black infants are also 3 times more likely to die and 60% more likely to be born prematurely than white babies. In a special program on KPBS Midday Edition we hear personal stories from Black mothers about their birthing experience, explore why the problem exists and what is being done to address it. |
December 10, 2020 | Announcement
Stat Madness 2021 CompetitionPlease think about if you have anyone in your department that should be nominated for the STAT Madness 2021 competition sponsored by STAT news (statnews.com) for the top innovation or discovery of 2020 in biomedical science. Nominations (and yes, one can self-nominate) must be received by me January 5, 2021. 64 potential winners will be selected from the eligible entries by STAT News editors beginning on January 19, 2021 and entries will be paired with each other in brackets for a single-elimination tournament (aka March Madness) until the final championship matchup. |
October 21, 2020 | Features Victor Nizet, MD
Start-up Receives up to $15 M to Develop Nanoparticle Therapy for Sepsis Licensed from UC San DiegoSan Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M from Boston-based accelerator CARB-X to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis. |
October 19, 2020 | Features Mark Sawyer, MDTwo from San Diego named to governor’s COVID-19 vaccine safety panelTwo San Diego physicians are among 11 experts statewide tasked with determining the quality of any new coronavirus vaccines released in the United States. |
September 23, 2020 | Features Tariq Rana, PhDStatins Reduce COVID-19 Severity, Likely by Removing Cholesterol That Virus Uses to InfectThere are no Food and Drug Administration (FDA)-approved treatments for COVID-19, the pandemic infection caused by a novel coronavirus. While several therapies are being tested in clinical trials, current standard of care involves providing patients with fluids and fever-reducing medications. To speed the search for new COVID-19 therapies, researchers are testing repurposed drugs — medicines already known to be safe for human use because they are FDA-approved for other conditions — for their abilities to mitigate the virus. |
September 9, 2020 | Features Alysson Muotri, PhD
How the Coronavirus Attacks the BrainIt’s not just the lungs — the pathogen may enter brain cells, causing symptoms like delirium and confusion, scientists reported. The coronavirus targets the lungs foremost, but also the kidneys, liver and blood vessels. Still, about half of patients report neurological symptoms, including headaches, confusion and delirium, suggesting the virus may also attack the brain. |
September 2, 2020 | Features Alessandra Franco, PhD
Innovator Spotlight: Alessandra FrancoDr. Franco has identified a set of immune modulatory peptides that stimulate Treg with great potency. The novelty resides in exploiting the adaptive immune regulation in a specific manner avoiding immune suppressive therapies, as steroids, that affects many efferent arms of the immune response. |
August 19, 2020 | Features Jane Burns, MD
New Data on How Many Kids Got That Covid Mystery IllnessA few young patients also develop strange inflammatory symptoms. A CDC report sheds light on how widespread this syndrome is, and what it could mean for vaccines. AS STUDENTS GO back to school across the United States, the assumption that children and teens play little role in spreading Covid-19 is taking a beating. One Georgia school district quarantined more than 900 students and adults. At another in Mississippi, more than 100 students were sent home. One Indiana high school didn’t even make it through a full day—and on Monday, the entire University of North Carolina reversed course on in-person learning and went fully remote. |
August 19, 2020 | Features Rob Knight, PhD
Human microbiome trims mucosal glycans, influencing SARS-CoV-2 infectionAn international team of researchers has conducted a study showing that differences in the human microbiome may influence the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells. These microbiome differences may help to explain why older individuals and men are more susceptible to developing coronavirus disease 19 (COVID-19), compared with younger individuals and women, says the team. |
August 4, 2020 | Features Sandra Leibel, MD
Researchers Growing Mini-Lungs To Study Coronavirus Impacts On Different Race, GenderSan Diego scientists are growing mini-lungs from a diverse set of stem cells to see how COVID-19 impacts the organ. Researchers are hoping the study shows how coronavirus affects people from different backgrounds. Researchers collected stem cells from people with different racial backgrounds and gender and then used them to grow organoids, or small functioning organs, in Petri dishes. |
August 3, 2020 | Features Tariq Rana, PhD
Inhibiting Enzyme Helps Cancer Immunotherapy Work BetterPeople with inactive RNA-editing enzyme respond better to immunotherapy; inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
Cancer immunotherapy — a treatment that better enables a patient’s own immune system to attack tumors — has shown great potential against some cancers. Yet immunotherapy doesn’t work against all tumor types, and many patients who initially respond later develop resistance and relapse. |
July 31, 2020 | Features Alysson Muotri, PhD
How Zero Gravity Can Reveal Basic Biological QuestionsAstronauts have conducted all sorts of experiments in the International Space Station—from observations of microgravity on the human to body to growing space lettuce. But recently, cosmonauts bioengineered human cartilage cells into 3D structures aboard the station, using a device that utilizes magnetic levitation. |
July 29, 2020 | Features Stephanie Cherqui, PhD
Best Life: Experimental Treatment for Cystinosis Featuring Dr. Stephanie CherquiThe Department of Pediatrics is excited to share this news clip that highlights Dr. Stephanie Cherqui’s experimental gene therapy approach to treating cystinosis. Stem cells taken from patient’s peripheral blood were re-engineered to produce functional cystinosin, the protein defective in cystinosis. The patient was then reinfused with his own cystinosin-producing cells. |
July 28, 2020 | Features Rob Knight, PhD
Watcher in the WastewaterResearch groups around the globe are looking to see whether urban wastewater monitoring can be integrated into surveillance systems for SARS-CoV-2 and other pathogens. After COVID-19 lockdowns eased across the United States in June, some parts of the country began reporting sudden increases in new cases. Texas was among the states leading the surge, and Houston in particular emerged as a national hotspot. |
July 24, 2020 | Features Stephen Spector, MD
National Clinical Trial Launches, Will Test Promising Vaccine Against Novel CoronavirusUC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19. |
July 23, 2020 | New PublicationSeema Aceves and team identified a new signaling pathway in eosinophilic eshophagitis that could lead to new therapeuticsIncreased production of LIGHT by T Cells in eosinophilic esophagitis promotes differentiation of esophageal fibroblasts toward an inflammatoryphenotype. |